Creating Digital Biomarkers with Real-World and Existing Data
XTalks
Archivo
02.02.2023 1235 Bay Street Suite 802, M5R 3K4 Toronto, Canada
Temas de la conferencia
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended. Validating a digital biomarker can be a huge task.
Organizador profesional (PCO)
Dryfta
Dryfta
Información e inscripción:
Mr. Andrew Juurinen
Farmacología y Toxicología
Idioma
Inglés
Inglés
Cuota del Congreso
Entrada libre
Entrada libre
Los participantes esperaban
150
150
Cantacto organizador
Suite B2,
19702 Newark
USA
Suite B2,
19702 Newark
USA
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
